Abstract
Phosphatidylinositol (PtdIns) and phosphatidylinositol 4-phosphate (PtdIns4P) kinase activities in plasma membranes isolated from canine left ventricle were partially characterized, and their sensitivity to a number of intracellular variables was established. PtdIns and PtdIns4P kinase activities were estimated by the formation of [32P]PtdIns4P and [32P]phosphatidylinositol 4,5-bisphosphate ([32P]PtdIns(4,5)P2), respectively, when membranes were incubated with [γ-32P]ATP and 0.1% Triton X-100. Unlike [32P]-PtdIns4P formation, [32P]PtdIns(4,5)P2 formation required exogenous (PtdIns4P) substrate. [32P]-PtdIns4P and [32P]PtdIns(4,5)P2 formation were insensitive to Ca2+ at concentrations ranging from 0.1–30 μM. The hydrolysis of [32P]PtdIns4P was less than 15% under standard assay conditions for measuring its formation, and was unaffected by any of the variables tested. The apparent Km of the PtdIns kinase for ATP was 53±13 (S.E.M.) μM (N=3). ADP inhibited [32P]PtdIns4P formation competitively with respect to ATP, the Ki being 0.4 mM. The data indicate that ADP is a poor competitive inhibitor of PtdIns kinase at the concentrations which are believed to be present intracellularly normally or which may be attained during mild hypoxia provided ATP levels are maintained in the millimolar range. Hence, any response of the myocardium to α-adrenergic hormones during mild hypoxia would be largely unimpaired by effects of Ca2+ on PtdIns and PtdIns(4,5)P2, or of ADP on PtdIns kinase activity.
Similar content being viewed by others
Abbreviations
- PtdIns:
-
phosphatidylinositol
- PtdIns4P:
-
phosphatidylinositol 4-phosphate
- PtdIns(4,5)P2 :
-
phosphatidylinositol (4,5)-bisphosphate
- Ins(1,4,5)P3 :
-
inositol (1,4,5)-trisphosphate
- PS:
-
phosphatidylserine
- PC:
-
phosphatidylcholine
- SR:
-
sarcoplasmic reticulum
- EGTA:
-
[ethylenebis(oxyethylenenitrilo)]tetraacetic acid
- Hepes:
-
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
References
Bruckner, R., Mugge, A., and Scholz, H. (1985)J. Mol. Cell. Cardiol., 17, 639–645.
Brown, J.H., Buxton, I.L., and Brunton, L.L. (1985)Circ. Res. 57, 532–537.
Brown, J.H., and Jones, L.G. (1986) inPhosphoinositides and Receptor Mechanisms in the Heart, pp. 245–270, Alan R. Liss, Inc., New York.
Harwood, J.L., and Hawthorne, J.N. (1969)Biochim. Biophys. Acta 171, 75–88.
Varsanyi, M., Messer, M., Brandt, N.R., and Heilmeyer, L.M.G., Jr. (1986),Biochem. Biophys. Res. Commun. 138, 1395–1404.
Kasinathan, C., and Kirchberger, M.A. (1988)Biochemistry 25, 5484–5492.
Quist, E.E., Kriewaldt, S.D., and Powell, P.A. (1989)FASEB J. 3, A371.
Georgoussi, Z., and Heilmeyer, L.M.G., Jr. (1986)Biochemistry 25, 3867–3874.
Rana, R.S., and MacDonald, M.J. (1986)Horm. Metab. Res. 18, 659–662.
Schafer, M., Behle, G., Varsanyi, M., and Heilmeyer, L.M.G., Jr., (1987)Biochem. J. 247, 579–587.
Carrasco, M.A., Madendzo, K., Jaimovich, E., and Hildalgo, C. (1988)Arch. Biochem. Biophys. 262, 360–366.
Kasinathan, C., Borchman, D., and Kirchberger, M.A. (1987)Biophys. J. 51, 402a.
Jones, L.R., and Besch, H.R., Jr. (1984)Meth. Pharmacol. 5, 1–12.
Tomlins, B., Harding, S.E., Kirby, S.K., Poole-Wilson, P.A., and Williams, A.J. (1986)Biochim. Biophys. Acta 856, 137–143.
Fleischer, B., and Smigel, M. (1978)J. Biol. Chem. 253, 1632–1638.
Manalon, A.S., and Jones, L.R. (1982)J. Biol. Chem. 257, 10052–10062.
Kirchberger, M.A., and Antonetz, T. (1982)J. Biol. Chem. 257, 5685–5691.
O'Sullivan, W.J., and Perrin, D.D. (1964)Biochemistry 3, 18–26.
Dixon, M., and Webb, E.D. (1979) Enzymes 3rd edn. pp. 332–467. Academic Press, New York.
Jergil, B., and Sundler, R. (1983)J. Biol. Chem. 258, 7968–7973.
Coco, A., and Macara, I.G. (1986)Am. J. Physiol. 251, (Cell Physiol. 20), C883-C886.
Doctrow, S.R., and Lowenstein, J.M. (1985)J. Biol. Chem. 260, 3469–3476.
Kammermeier, H., Schmidt, P., and Jungling, E. (1982)J. Mol. Cell. Cardiol. 14, 267–277.
Endeman, G., Dunn, S.M., and Cantley, L.C. (1987)Biochemistry 26, 6845–6852.
Buckley, J.T. (1977)Biochim. Biophys. Acta 498, 1–9.
Michell, R.H., Kirk, C.J., Maccallum S.H., and Hunt, P.A. (1988)Phil. Trans. R. Soc. Lond. B 320, 239–246.
Hou, W-M., Zhang, Z.L., and Tai, H.H. (1988)Biochim. Biophys. Acta 959, 67–75.
Smith, C.D., and Wells, W.W. (1983)J. Biol. Chem. 258, 9368–9373.
O'Shea, J.J., Harford, J.B., and Klausner, R.D. (1986)J. Immunol. 137, 971–976.
Soboll, S., and Bunger, R. (1981)Hoppe-Seyler's Z. Physiol. Chem. 362, 125–132.
Allen, D.G., and Orchard, C.H. (1987)Circulation Res. 60, 153–168.
Author information
Authors and Affiliations
About this article
Cite this article
Kasinathan, C., Xu, Z.C. & Kirchberger, M.A. Polyphosphoinositide formation in isolated cardiac plasma membranes. Lipids 24, 818–823 (1989). https://doi.org/10.1007/BF02544590
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02544590